Aripiprazole

Product manufactured by Orchidpharma Inc

Application Nr Approved Date Route Status External Links
ANDA202547 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Aripiprazole Orally Disintegrating Tablets Are Indicated For The Treatment Of: Schizophrenia [See Clinical Studies (14.1)] Additional Pediatric Use Information Is Approved For Otsuka America Pharmaceutical, Inc.’s Abilify ® (Aripiprazole) Product. However, Due To Otsuka America Pharmaceutical, Inc.’s Marketing Exclusivity Rights, This Drug Product Is Not Labeled With That Information. Aripiprazole Orally Disintegrating Tablets Are An Atypical Antipsychotic. The Oral Formulations Are Indicated For: Schizophrenia (14.1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Aripiprazole ARIPIPRAZOLE ZINC1851149

Comments